PT Bundamedik Tbk 2021 SR
The report highlights PT Bundamedik Tbk's (BMHS) first year as a public company, focusing on its "continuity of care" strategy from embryo to old age. Key achievements in 2021 include a 49% increase in revenue and a 166% rise in net profit, driven by expanded health services and COVID-19 response. The company expanded its network to nearly 50 Morula specialist clinics and added 15 new laboratories. Environmental efforts focused on energy and water efficiency, including trials of solar panels at two hospitals. Social initiatives included providing COVID-19 vaccinations and various CSR programs benefiting the community.
Company: PT Bundamedik Tbk
Sector: Healthcare & social services
Country: Indonesia
Year: 2021
Type: SR
Pages: 80
PT Bundamedik Tbk
The report highlights PT Bundamedik Tbk's (BMHS) first year as a public company, focusing on its "continuity of care" strategy from embryo to old age. Key achievements in 2021 include a 49% increase in revenue and a 166% rise in net profit, driven by expanded health services and COVID-19 response. The company expanded its network to nearly 50 Morula specialist clinics and added 15 new laboratories. Environmental efforts focused on energy and water efficiency, including trials of solar panels at two hospitals. Social initiatives included providing COVID-19 vaccinations and various CSR programs benefiting the community.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jan 1, 2021 - Dec 31, 2021
Fiscal Year
2021
Published
May 1, 2022
Type
Sustainability Report
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Total Waste
Women on Board
Employees